Zhenglong Zhai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhenglong Zhai has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Lu Wang
School of Pharmaceutical Sciences MOE Key Laboratory of Smart Drug Delivery MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases Fudan University Shanghai China
3 shared publications Rui Bao
School of Pharmaceutical Sciences MOE Key Laboratory of Smart Drug Delivery MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases Fudan University Shanghai China
3 shared publications- Hanqing Zhao
School of Pharmaceutical Sciences MOE Key Laboratory of Smart Drug Delivery MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases Fudan University Shanghai China
2 shared publications Hao Rong
School of Physical Science and Technology State Key Laboratory of Advanced Medical Materials and Devices ShanghaiTech University Shanghai China
2 shared publicationsJingjing Xie
School of Physical Science and Technology State Key Laboratory of Advanced Medical Materials and Devices ShanghaiTech University Shanghai China
2 shared publicationsJuncheng Chen
School of Physical Science and Technology State Key Laboratory of Advanced Medical Materials and Devices ShanghaiTech University Shanghai China
2 shared publications
Latest Publications
- 31 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e5772233
A Compact Fluorogenic Peptide Tag for Bright Wash‐Free Live‐Cell Imaging
Live‐cell fluorescence imaging offers profound insights into cellular biology, yet achieving strong fluorescence signals with minimal labeling footprint and perturbation to proteins of interest remains a persistent challenge. Here we introduce FluoP‐tag, a compact fluorogenic peptide‐tag platform for tandem‐array engineering in live cells. FluoP‐tag combines a 31‐residue peptide (∼3.4 kDa) with a cell‐permeable fluorogenic dye, FluoP580 (568 Da), rationally engineered to undergo peptide‐triggered switching from a non‐emissive spirolactam state to an emissive zwitterionic state. This compact design enables wash‐free intracellular labeling and copy‐number‐dependent signal amplification in tandem‐array formats. An 8×FluoP array produced 3.37‐fold higher brightness than HaloTag labeled with a Rhodamine X‐derived probe while remaining smaller overall (∼29.5 kDa vs. ∼33 kDa). FluoP‐tag arrays further enabled protein imaging across diverse intracellular compartments, spanning biomolecular condensates in stress granules, the nucleus, and the nucleolus, and cytoskeletal architectures resolved by live‐cell structured illumination microscopy (SIM). FluoP‐tag provides a compact fluorogenic tag‐array platform for protein labeling and imaging in living cells.
- 31 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e5772233
A Compact Fluorogenic Peptide Tag for Bright Wash‐Free Live‐Cell Imaging
Live‐cell fluorescence imaging offers profound insights into cellular biology, yet achieving strong fluorescence signals with minimal labeling footprint and perturbation to proteins of interest remains a persistent challenge. Here we introduce FluoP‐tag, a compact fluorogenic peptide‐tag platform for tandem‐array engineering in live cells. FluoP‐tag combines a 31‐residue peptide (∼3.4 kDa) with a cell‐permeable fluorogenic dye, FluoP580 (568 Da), rationally engineered to undergo peptide‐triggered switching from a non‐emissive spirolactam state to an emissive zwitterionic state. This compact design enables wash‐free intracellular labeling and copy‐number‐dependent signal amplification in tandem‐array formats. An 8×FluoP array produced 3.37‐fold higher brightness than HaloTag labeled with a Rhodamine X‐derived probe while remaining smaller overall (∼29.5 kDa vs. ∼33 kDa). FluoP‐tag arrays further enabled protein imaging across diverse intracellular compartments, spanning biomolecular condensates in stress granules, the nucleus, and the nucleolus, and cytoskeletal architectures resolved by live‐cell structured illumination microscopy (SIM). FluoP‐tag provides a compact fluorogenic tag‐array platform for protein labeling and imaging in living cells.
- 31 October 2026
- Published by Wiley in Angewandte Chemie
A Compact Fluorogenic Peptide Tag for Bright Wash‐Free Live‐Cell Imaging
Live‐cell fluorescence imaging offers profound insights into cellular biology, yet achieving strong fluorescence signals with minimal labeling footprint and perturbation to proteins of interest remains a persistent challenge. Here we introduce FluoP‐tag, a compact fluorogenic peptide‐tag platform for tandem‐array engineering in live cells. FluoP‐tag combines a 31‐residue peptide (∼3.4 kDa) with a cell‐permeable fluorogenic dye, FluoP580 (568 Da), rationally engineered to undergo peptide‐triggered switching from a non‐emissive spirolactam state to an emissive zwitterionic state. This compact design enables wash‐free intracellular labeling and copy‐number‐dependent signal amplification in tandem‐array formats. An 8×FluoP array produced 3.37‐fold higher brightness than HaloTag labeled with a Rhodamine X‐derived probe while remaining smaller overall (∼29.5 kDa vs. ∼33 kDa). FluoP‐tag arrays further enabled protein imaging across diverse intracellular compartments, spanning biomolecular condensates in stress granules, the nucleus, and the nucleolus, and cytoskeletal architectures resolved by live‐cell structured illumination microscopy (SIM). FluoP‐tag provides a compact fluorogenic tag‐array platform for protein labeling and imaging in living cells.
- 31 October 2026
- Published by Wiley in Angewandte Chemie
A Compact Fluorogenic Peptide Tag for Bright Wash‐Free Live‐Cell Imaging
Live‐cell fluorescence imaging offers profound insights into cellular biology, yet achieving strong fluorescence signals with minimal labeling footprint and perturbation to proteins of interest remains a persistent challenge. Here we introduce FluoP‐tag, a compact fluorogenic peptide‐tag platform for tandem‐array engineering in live cells. FluoP‐tag combines a 31‐residue peptide (∼3.4 kDa) with a cell‐permeable fluorogenic dye, FluoP580 (568 Da), rationally engineered to undergo peptide‐triggered switching from a non‐emissive spirolactam state to an emissive zwitterionic state. This compact design enables wash‐free intracellular labeling and copy‐number‐dependent signal amplification in tandem‐array formats. An 8×FluoP array produced 3.37‐fold higher brightness than HaloTag labeled with a Rhodamine X‐derived probe while remaining smaller overall (∼29.5 kDa vs. ∼33 kDa). FluoP‐tag arrays further enabled protein imaging across diverse intracellular compartments, spanning biomolecular condensates in stress granules, the nucleus, and the nucleolus, and cytoskeletal architectures resolved by live‐cell structured illumination microscopy (SIM). FluoP‐tag provides a compact fluorogenic tag‐array platform for protein labeling and imaging in living cells.
- Open Access
- 19 August 2026
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
Live-Cell Fluorescent Imaging of Pyridine Nucleotide Coenzymes: Sensor Platforms, Biological Applications, and Pharmacological Opportunities
Pyridine nucleotide coenzymes, including NAD+/NADH and NADP+/NADPH redox couples, form a highly interconnected metabolic and signaling network that links cellular bioenergetics, biosynthesis, redox homeostasis, and stress responses. These cofactors are compartmentalized across the cytosol, mitochondria, and nucleus and are continuously remodeled by multiple biosynthetic, recycling, interconversion, and consumption pathways. Their spatiotemporal dynamics are further rewired in cancer, aging, neurodegeneration, and inflammation, making them informative reporters of pathway activity and attractive pharmacological targets. In this review, we discuss fluorescent biosensors for pyridine nucleotide imaging, including small-molecule probes, genetically encoded indicators, and chemigenetic platforms. We compare these approaches in terms of analyte definition, selectivity, dynamic range, reversibility, spatiotemporal resolution, and suitability for subcellular imaging. We then summarize what these tools have revealed about the networked regulation of pyridine nucleotide coenzymes in physiology and disease and highlight their growing utility in drug discovery, mechanism-of-action studies, and phenotypic screening. Finally, we outline the technical challenges that must be addressed to make pyridine nucleotide imaging more quantitative, interoperable, and predictive in chemical biology and biomedicine.
- 19 August 2026
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
Open AccessLive-Cell Fluorescent Imaging of Pyridine Nucleotide Coenzymes: Sensor Platforms, Biological Applications, and Pharmacological Opportunities
Pyridine nucleotide coenzymes, including NAD+/NADH and NADP+/NADPH redox couples, form a highly interconnected metabolic and signaling network that links cellular bioenergetics, biosynthesis, redox homeostasis, and stress responses. These cofactors are compartmentalized across the cytosol, mitochondria, and nucleus and are continuously remodeled by multiple biosynthetic, recycling, interconversion, and consumption pathways. Their spatiotemporal dynamics are further rewired in cancer, aging, neurodegeneration, and inflammation, making them informative reporters of pathway activity and attractive pharmacological targets. In this review, we discuss fluorescent biosensors for pyridine nucleotide imaging, including small-molecule probes, genetically encoded indicators, and chemigenetic platforms. We compare these approaches in terms of analyte definition, selectivity, dynamic range, reversibility, spatiotemporal resolution, and suitability for subcellular imaging. We then summarize what these tools have revealed about the networked regulation of pyridine nucleotide coenzymes in physiology and disease and highlight their growing utility in drug discovery, mechanism-of-action studies, and phenotypic screening. Finally, we outline the technical challenges that must be addressed to make pyridine nucleotide imaging more quantitative, interoperable, and predictive in chemical biology and biomedicine.
- 24 April 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (8) , e202500971
Harnessing S. aureus tRNA Guanine Transglycosylase for Efficient Site‐Specific Covalent Labeling of DNA
Site‐specific DNA modification enables the construction of functional nucleic acid architectures for imaging, diagnostics, and information encoding. Bacterial tRNA guanine transglycosylases (TGTs) have been shown to exchange guanine‐34 in cognate tRNAs for prequeuosine1 (preQ1) analogs. Escherichia coli TGT (EcTGT) has been widely harnessed for site‐specific RNA labeling. However, EcTGT exhibits slow labeling kinetics and lower efficiency on DNA. Here, we demonstrate that TGT from Staphylococcus aureus (SaTGT) is a superior enzyme for DNA modification. Like EcTGT, SaTGT recognizes only the anticodon stem‐loop and efficiently modifies the DNA hairpin dECYMH, whereas EcTGT shows no appreciable modification. Using the S. aureus tRNA His ‐based hairpin as a starting point, we identified the most promising scaffolds. Rational loop optimization yielded dSAH‐6, which is labeled by SaTGT with near‐quantitative conversion under standard conditions. Side‐by‐side comparisons revealed that SaTGT outperforms EcTGT in both yield and kinetics across multiple preQ1 derivatives and hairpin sequences. Importantly, the optimized dSAH‐6 sequence enables robust labeling at 5′‐, 3′‐, or internal positions in longer ssDNA constructs and supports efficient multi‐site incorporation. These findings significantly expand the DNA‐TAG toolbox and highlight how natural variation in TGT substrate promiscuity can be exploited for improved nucleic acid modification technologies.
- 24 April 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (8) , e202500971
Harnessing S. aureus tRNA Guanine Transglycosylase for Efficient Site‐Specific Covalent Labeling of DNA
Site‐specific DNA modification enables the construction of functional nucleic acid architectures for imaging, diagnostics, and information encoding. Bacterial tRNA guanine transglycosylases (TGTs) have been shown to exchange guanine‐34 in cognate tRNAs for prequeuosine1 (preQ1) analogs. Escherichia coli TGT (EcTGT) has been widely harnessed for site‐specific RNA labeling. However, EcTGT exhibits slow labeling kinetics and lower efficiency on DNA. Here, we demonstrate that TGT from Staphylococcus aureus (SaTGT) is a superior enzyme for DNA modification. Like EcTGT, SaTGT recognizes only the anticodon stem‐loop and efficiently modifies the DNA hairpin dECYMH, whereas EcTGT shows no appreciable modification. Using the S. aureus tRNA His ‐based hairpin as a starting point, we identified the most promising scaffolds. Rational loop optimization yielded dSAH‐6, which is labeled by SaTGT with near‐quantitative conversion under standard conditions. Side‐by‐side comparisons revealed that SaTGT outperforms EcTGT in both yield and kinetics across multiple preQ1 derivatives and hairpin sequences. Importantly, the optimized dSAH‐6 sequence enables robust labeling at 5′‐, 3′‐, or internal positions in longer ssDNA constructs and supports efficient multi‐site incorporation. These findings significantly expand the DNA‐TAG toolbox and highlight how natural variation in TGT substrate promiscuity can be exploited for improved nucleic acid modification technologies.